Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_4
2
33%
Ph phase_1
1
17%
Ph phase_2
3
50%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 4Post-market surveillance
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 42 (33.3%)

Trials by Status

recruiting117%
completed583%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_2

Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer

NCT06826079
completedphase_2

Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease

NCT04330326
completedphase_2

Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients

NCT04044131
completedphase_4

A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers

NCT02634073
completedphase_1

Effect of Xylitol on Oral Microbiota in Children

NCT01528969
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06826079Phase 2

Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer

Recruiting
NCT04330326Phase 2

Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease

Completed
NCT04044131Phase 2

Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients

Completed
NCT02634073Phase 4

A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers

Completed
NCT01528969Phase 1

Effect of Xylitol on Oral Microbiota in Children

Completed
NCT00638677Phase 4

Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6